✦ LIBER ✦

An Advanced Generation of Adenoviral Vectors Selectively Enhances Gene Transfer for Ovarian Cancer Gene Therapy Approaches

✍ Scribed by Timothy J. Vanderkwaak; Minghui Wang; Jesús Gómez-Navarro; Claudine Rancourt; Igor Dmitriev; Victor Krasnykh; Mack Barnes; Gene P. Siegal; Ronald Alvarez; David T. Curiel

Book ID: 112247757
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 295 KB
Volume: 74
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1999.5432

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical evaluation of a class of inf

Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy

✍ Wu, H; Han, T; Lam, J T; Leath, C A; Dmitriev, I; Kashentseva, E; Barnes, M N; A 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 240 KB

Preclinical Studies of a New Generation

Preclinical Studies of a New Generation Retroviral Vector for Ovarian Cancer BRCA1 Gene Therapy

✍ David L. Tait; Patrice S. Obermiller; Jeffrey T. Holt 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Elevated activated partial thromboplasti

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: Identification of lupus anticoagulants

✍ Bahaa S. Malaeb; Thomas A. Gardner; Vitaly Margulis; Ling Yang; Jay Y. Gillenwat 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Adenoviral vector–mediated gene transfer

Adenoviral vector–mediated gene transfer of IL-13Rα2 chain followed by IL-13 cytotoxin treatment offers potent targeted therapy for cytotoxin-resistant cancers

✍ Makoto Saito; Takashi Murata; Ken Watanabe; Koji Kawakami; Motoyoshi Suzuki; Tak 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 404 KB

## Abstract Previous studies demonstrated that IL‐13Rα2 chain–overexpressing cancer cells were highly sensitive to IL‐13 cytotoxin (IL13‐PE38QQR) and could be targeted by cytotoxin treatment. However, the majority of human tumors do not express high levels of IL‐13Rα2 chain. To expand the IL‐13 cyt

A nonreplicating adenoviral vector that

A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer : Safety, efficacy, and biologic activity of a novel gene-therapy approach

✍ Massimo Cristofanilli; Savitri Krishnamurthy; Laura Guerra; Kristine Broglio; Ba 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 1 views